0 Ask Beta Account

DOUBLE‐BLIND CONTROLLED TRIAL OF 6‐METHYL, 17‐ACETOXYPROGESTERONE IN THREATENED ABORTION

K. J. Alling Møller, Fritz Fuchs

  • NewYork–Presbyterian Hospital ROR

BJOG: An International Journal of Obstetrics & Gynaecology, 72(6), 1042-1044

DOI 10.1111/j.1471-0528.1965.tb01540.x Source

Abstract

No abstract available for this article.

Topics

Pregnancy > Threatened Abortion > Progestogen TherapyPregnancy > Miscarriage Prevention > Randomized Controlled TrialsReproductive Endocrinology > Progesterone > Therapeutic Use in Pregnancy
medroxyprogesterone acetate threatened abortion double blind trial, 6-methyl 17-acetoxyprogesterone threatened miscarriage randomized trial, progestogen therapy threatened abortion controlled trial, Møller Fuchs progesterone threatened abortion clinical trial, synthetic progesterone prevention miscarriage double blind study, progestational agent threatened abortion 1960s trial, threatened miscarriage hormonal treatment effectiveness, progesterone supplementation early pregnancy loss prevention, double blind controlled trial progestogen pregnancy maintenance, recurrent pregnancy loss progestational therapy evidence
DOI 10.1111/j.1471-0528.1965.tb01540.x 10.1111/j.1471-0528.1965.tb01540.x

Cite this article

Moller, K. J. A., & Fuchs, F. (1968). *Double-Dash Blind Controlled Trial of 6-Methyl, 17-Acetoxyprogesterone in Threatened Abortion*.

Related articles

Hormones in Recurrent Abortion
Klopper A et al., 1966 BJOG: An International Journal of Obstetrics & Gynaecology
Infertility > Recurrent Pregnancy Loss > Hormonal FactorsReproductive Endocrinology > Hormonal Assessment > Pregnancy Loss